The Riverside Co. has sold its Simcro platform to Datamars SA, marking its first exit in New Zealand and 7th overall in the Asia-Pacific region. Simcro Ltd., which makes pharmaceutical delivery devices for the animal health industry, joined Riverside’s portfolio in 2013. The investment firm helped Simcro grow considerably during the hold, with EBITDA roughly tripling on the back of strong investment in new product development and in the global sales and marketing team. Riverside helped Simcro establish new offices in the United States, Asia and Latin America to complement the existing footprint of the business in New Zealand, Australia and UK/Europe. It also helped Simcro acquire and then integrate the add-ons of ISL Animal Health and NJ Phillips, which delivered scale and an enhanced product portfolio to drive customer engagement and supply chain efficiencies. Working with Riverside Partner Steven Spiteri on the transaction were Managing Partner Simon Feiglin and Senior Associate Kevin Xu. Riverside received the following support:
- Corporate and strategic advice from First NZ Capital
- Legal advice from Russell McVeagh
- Financial and tax advice from KPMG
